New VP, Investor Relations At Johnson & Johnson
Johnson & Johnson has appointed Joseph Wolk vice president of investor relations, replacing Louise Mehrotra, who will retire in January 2017 after over 10 years at the company. Wolk was previously vice president of group finance for the pharmaceuticals group of Johnson & Johnson, before which he held several other financial leadership positions within the business, including vice president of finance for the medical devices global supply chain, and chief financial officer of the North America pharmaceuticals group.
You may also be interested in...
The company said its own calculations suggested a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
New Chief Technology Officers named at Seres Therapeutics, ERYTech Pharma and Adicet Bio
Swiss biotech Molecular Partners will receive upfront payment of CHF60m, including equity.